Cargando…

New treatment options in elderly patients with Diffuse Large B-cell Lymphoma

Most patients with Diffuse Large B-cell Lymphoma (DLBCL) are old (>65 years of age) and this population is expected to increase in the following years. A simplified geriatric assessment based on a careful evaluation of the fitness status and comorbidities is essential to choose the correct intens...

Descripción completa

Detalles Bibliográficos
Autores principales: Arcari, Annalisa, Cavallo, Federica, Puccini, Benedetta, Vallisa, Daniele
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10351275/
https://www.ncbi.nlm.nih.gov/pubmed/37465115
http://dx.doi.org/10.3389/fonc.2023.1214026